Holen Sie sich die Stockscreener-App
4.61
4.95%
-0.24
Handel nachbörslich:
4.48
-0.13
-2.82%
Schlusskurs vom Vortag:
$4.85
Offen:
$4.76
24-Stunden-Volumen:
3.85M
Relative Volume:
0.81
Marktkapitalisierung:
$1.63B
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-11.82
EPS:
-0.39
Netto-Cashflow:
$-68.47M
1W Leistung:
+10.29%
1M Leistung:
+24.93%
6M Leistung:
+171.18%
1J Leistung:
+290.68%
1-Tages-Spanne:
$4.385
$4.82
1-Wochen-Bereich:
$4.01
$4.95
52-Wochen-Spanne:
$1.05
$5.225
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Vergleichen Sie PGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.61 | 1.72B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Can Precigen Inc. stock beat market expectations this quarterJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - ulpravda.ru
Can Precigen Inc. stock double in next 5 yearsJuly 2025 Rallies & Entry Point Strategy Guides - ulpravda.ru
Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic? - simplywall.st
Will Precigen Inc. stock recover faster than peersGeopolitical Risk Analysis & Amplify Gains With Picks - ulpravda.ru
Will Precigen Inc. stock see insider buying2026 world cup usa national team quarterfinals star players possession football tactical prediction insights - ulpravda.ru
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference - Finviz
Precigen (NASDAQ:PGEN) Trading Down 6.1%What's Next? - MarketBeat
Precigen (NASDAQ:PGEN) Trading Down 4.2%Here's What Happened - MarketBeat
Will PGEN’s New Drug Make a Splash? - StocksToTrade
Precigen (NASDAQ:PGEN) Shares Up 5.1%What's Next? - MarketBeat
DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga
Precigen (NASDAQ:PGEN) Advances Genetic Medicine Platforms - Kalkine Media
Precigen (NASDAQ:PGEN) Shares Gap Down Following Insider Selling - MarketBeat
Monday’s Insider Activity: Andreessen Horowitz Leads Major Buys - Investing.com
Monday’s Insider Activity: Andreessen Horowitz Leads Major Buys By Investing.com - Investing.com UK
Precigen Insider Sold Shares Worth $7,942,150, According to a Recent SEC Filing - marketscreener.com
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 1,900,036 Shares of Stock - MarketBeat
Kirk sells Precigen shares worth $7.9 million By Investing.com - Investing.com South Africa
Kirk sells Precigen shares worth $7.9 million - Investing.com
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Profit Review: Will Precigen Inc. stock see insider buyingInsider Selling & Real-Time Buy Signal Alerts - Улправда
Is Precigen Inc. stock a buy before product launchesTrade Risk Assessment & Real-Time Stock Entry Alerts - Улправда
Is Precigen Inc. stock a buy on dips2025 Price Targets & Verified Swing Trading Watchlists - ulpravda.ru
Sentiment Watch: Is Precigen Inc. stock a buy before product launchesJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
Market Outlook: Is Precigen Inc. stock a buy on dipsWeekly Profit Report & Real-Time Volume Analysis - ulpravda.ru
Precigen, Inc. (PGEN) Stock Analysis: Exploring a 103.84% Upside Potential in the Booming Biotech Sector - DirectorsTalk Interviews
Trade Alert: Independent Director Of Precigen Jeffrey Kindler Has Sold Stock - simplywall.st
PRECIGEN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased - PR Newswire
Working capital per share of Precigen Inc – SWB:I5X - TradingView — Track All Markets
Precigen (PGEN) director reports sale of 235,467 shares of common stock on 12/12/2025 - Stock Titan
US High Growth Tech Stocks To Watch December 2025 - simplywall.st
Precigen Director Jeffrey B Kindler Sells 235,467 Shares - TradingView — Track All Markets
Spotlighting Bridgewater Bancshares And 2 Other Growth Stocks With Strong Insider Ownership - simplywall.st
Precigen Earnings Notes - Trefis
Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company - Yahoo Finance
Dir Kindler Files To Sell 235,467 Of Precigen Inc [PGEN] - TradingView — Track All Markets
Precigen (NASDAQ:PGEN) Trading 5.3% HigherHere's What Happened - MarketBeat
Diametric Capital LP Buys New Holdings in Precigen, Inc. $PGEN - MarketBeat
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet? - sharewise.com
Patient Capital Management LLC Sells 1,103,560 Shares of Precigen, Inc. $PGEN - MarketBeat
Precigen (PGEN): Valuation in Focus After FDA Approval and Strengthened Cash Position - Sahm
Free cash flow per share of Precigen Inc – BX:I5X - TradingView
Precigen, Inc. (NASDAQ:PGEN) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Precigen's (PGEN) Revenue Surge Offset Concerns About Its Expanding Losses? - simplywall.st
Precigen (NASDAQ:PGEN) Trading Down 4.9%Here's Why - MarketBeat
Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN) - Seeking Alpha
Precigen Insider Sold Shares Worth $12,291,748, According to a Recent SEC Filing - marketscreener.com
Precigen, Inc. Opens with a 5.13% Gain Amid Ongoing Challenges - Markets Mojo
Precigen, Inc. Soars 26.94% to Hit Intraday High of $5.00 - Markets Mojo
Precigen, Inc. Hits Day High with 25.65% Surge in Stock Price - Markets Mojo
Is Precigen (NASDAQ:PGEN) Weighed On By Its Debt Load? - 富途牛牛
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):